|
The Heart & Vascular Center CLINICAL RESEARCH DEPARTMENT
|
|
|
The Heart & Vascular Center is home to a
large and nationally recognized clinical research department. At present, 33 clinical
trials are underway, studying an assortment of medications to treat multiple cardiac and
general disease states. These carefully designed studies utilize patients who volunteer to
receive investigational treatments, all under the close supervision of a physician and
other research professionals. Such research is necessary to obtain Food and Drug
Administration (FDA) approval on any new medication, but also helpful later to help assess
a medication's long-term safety, effectiveness, cost, and impact on quality of life. The Heart & Vascular Center's Clinical Research Department is directed by Randy Hartman, M.D. FACC, and managed by Colleen Little. With a data base of over 90,000 patients, seven affiliated hospitals, six separate offices and 25 board-certified Cardiologists, the Heart Center has the necessary resources to conduct these studies in the safest, most effective manner. Current studies are underway on medications to prevent and/or treat such cardiac diseases as acute myocardial infarction (heart attack), congestive heart failure, hypertension, and atrial fibrillation. Additionally, the department has now entered into a partnership with internal medicine physicians to broaden its scope and now has the capability to study medications to treat a variety of other diseases, such as diabetes, depression, osteoporosis and Alzheimer's Disease, among others. Participants in these studies receive their trial medications and all related medical treatment at no cost. They may elect to drop out of the studies at any time and for any reason. Many volunteers are motivated by the desire to obtain the latest breakthrough treatment for their disease, or to receive high-quality, low-cost medical care. Even the uninsured are eligible to participate. Because there are some diseases for which there presently are no cures or viable treatments approved by the FDA, research studies may offer these participants more hope than conventional medical care. Study participants are instrumental to the advancement of medical science. All modern medical treatments owe their existence to those who have participated in the clinical research phase of drug development. The studies are invaluable in the development of new medical therapies (and even cures) for life-threatening and chronic diseases. Patients interested in participating in a Heart & Vascular Center study are advised to call the research department in Sarasota at (941)957-3079 or (800)226-0433. Links for sponsors: http://www.rp-rorer.com/
|
|
|
|
|